oxyquinoline has been researched along with Acute Confusional Senile Dementia in 13 studies
Oxyquinoline: An antiseptic with mild fungistatic, bacteriostatic, anthelmintic, and amebicidal action. It is also used as a reagent and metal chelator, as a carrier for radio-indium for diagnostic purposes, and its halogenated derivatives are used in addition as topical anti-infective agents and oral antiamebics.
quinolin-8-ol : A monohydroxyquinoline that is quinoline substituted by a hydroxy group at position 8. Its fungicidal properties are used for the control of grey mould on vines and tomatoes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "Alzheimer's disease is the most common neurodegenerative disease of the elderly and although some drugs may delay cognitive impairment, an effective treatment has not yet been found." | 2.45 | Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer's disease. ( Bica, L; Cappai, R; Crouch, PJ; White, AR, 2009) |
| "Although Alzheimer's disease (AD) was first described over a century ago, it remains the leading cause of age-related dementia." | 1.72 | Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs. ( Dolgova, NV; George, GN; Harris, HH; Kroll, T; Millhauser, GL; Pickering, IJ; Pushie, MJ; Roseman, G; Schilling, KM; Sokaras, D; Summers, KL, 2022) |
| "Biometals have an important role in AD (Alzheimer's disease) and metal ligands have been investigated as potential therapeutic agents for treatment of AD." | 1.34 | Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands. ( Barnham, KJ; Caragounis, A; Cherny, RA; Crouch, PJ; Drew, SC; Du, T; Filiz, G; Hill, AF; Laughton, KM; Li, QX; Masters, CL; Sharples, RA; Volitakis, I; White, AR, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Fernández-Bachiller, MI | 1 |
| Pérez, C | 1 |
| González-Muñoz, GC | 1 |
| Conde, S | 1 |
| López, MG | 1 |
| Villarroya, M | 1 |
| García, AG | 1 |
| Rodríguez-Franco, MI | 1 |
| Knez, D | 1 |
| Coquelle, N | 1 |
| Pišlar, A | 1 |
| Žakelj, S | 1 |
| Jukič, M | 1 |
| Sova, M | 1 |
| Mravljak, J | 1 |
| Nachon, F | 1 |
| Brazzolotto, X | 1 |
| Kos, J | 1 |
| Colletier, JP | 1 |
| Gobec, S | 1 |
| Summers, KL | 1 |
| Roseman, G | 1 |
| Schilling, KM | 1 |
| Dolgova, NV | 1 |
| Pushie, MJ | 1 |
| Sokaras, D | 1 |
| Kroll, T | 1 |
| Harris, HH | 1 |
| Millhauser, GL | 1 |
| Pickering, IJ | 1 |
| George, GN | 1 |
| Peng, YB | 1 |
| Tao, C | 1 |
| Tan, CP | 1 |
| Zhao, P | 1 |
| Kenche, VB | 1 |
| Zawisza, I | 1 |
| Masters, CL | 2 |
| Bal, W | 2 |
| Barnham, KJ | 2 |
| Drew, SC | 3 |
| de Freitas, LV | 1 |
| da Silva, CC | 1 |
| Ellena, J | 1 |
| Costa, LA | 1 |
| Rey, NA | 1 |
| Arain, MS | 1 |
| Arain, SA | 1 |
| Kazi, TG | 1 |
| Afridi, HI | 1 |
| Ali, J | 1 |
| Arain, SS | 1 |
| Brahman, KD | 1 |
| Mughal, MA | 1 |
| Prati, F | 1 |
| Bergamini, C | 1 |
| Fato, R | 1 |
| Soukup, O | 1 |
| Korabecny, J | 1 |
| Andrisano, V | 1 |
| Bartolini, M | 1 |
| Bolognesi, ML | 1 |
| Mital, M | 1 |
| Zawisza, IA | 1 |
| Wiloch, MZ | 1 |
| Wawrzyniak, UE | 1 |
| Kenche, V | 1 |
| Wróblewski, W | 1 |
| Bica, L | 1 |
| Crouch, PJ | 2 |
| Cappai, R | 1 |
| White, AR | 2 |
| Caragounis, A | 1 |
| Du, T | 1 |
| Filiz, G | 1 |
| Laughton, KM | 1 |
| Volitakis, I | 1 |
| Sharples, RA | 1 |
| Cherny, RA | 1 |
| Hill, AF | 1 |
| Li, QX | 1 |
| Deraeve, C | 1 |
| Boldron, C | 1 |
| Maraval, A | 1 |
| Mazarguil, H | 1 |
| Gornitzka, H | 1 |
| Vendier, L | 1 |
| Pitié, M | 1 |
| Meunier, B | 1 |
2 reviews available for oxyquinoline and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Extracellular Signal-Regulated MAP Kinases; Glyco | 2009 |
1 trial available for oxyquinoline and Acute Confusional Senile Dementia
11 other studies available for oxyquinoline and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Blood-Brain Barrier; B | 2010 |
Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Butyrylcholinesterase; Caco-2 Cells; Cell Li | 2018 |
Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Chelating Agents; Clioquinol; Copper; Humans; Ions; Metals | 2022 |
Inhibition of Aβ peptide aggregation by ruthenium(II) polypyridyl complexes through copper chelation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Benzimidazoles; Cell Line, Tumor; Cell Survival; Chelating | 2021 |
Mixed ligand Cu2+ complexes of a model therapeutic with Alzheimer's amyloid-β peptide and monoamine neurotransmitters.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Copper; Glutamic Acid; Glutathione Disulfide; Glycine; His | 2013 |
Structural and vibrational study of 8-hydroxyquinoline-2-carboxaldehyde isonicotinoyl hydrazone--a potential metal-protein attenuating compound (MPAC) for the treatment of Alzheimer's disease.
Topics: Aldehydes; Alzheimer Disease; Drug Discovery; Humans; Hydrazones; Metals; Models, Molecular; Oxyquin | 2013 |
Temperature controlled ionic liquid-based dispersive micro-extraction using two ligands, for determination of aluminium in scalp hair samples of Alzheimer's patients: a multivariate study.
Topics: Acids; Aged; Aluminum; Alzheimer Disease; Calibration; Case-Control Studies; Cognition Disorders; Fl | 2015 |
Novel 8-Hydroxyquinoline Derivatives as Multitarget Compounds for the Treatment of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Blood-Brain Barrier; Butyrylcholinesterase; | 2016 |
Copper Exchange and Redox Activity of a Prototypical 8-Hydroxyquinoline: Implications for Therapeutic Chelation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Copper; Electron Spin Resonance Spectroscopy; Humans; Kine | 2016 |
Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Biological Transport, Active; CHO Cells; Copper; | 2007 |
Preparation and study of new poly-8-hydroxyquinoline chelators for an anti-Alzheimer strategy.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Chelating Agents; Copper; Crystallography, X-Ray; Hydrogen | 2008 |